Ilyang Pharmaceutical Co.,Ltd (007575.KS) KSC

Currency In KRW

AD

Valuation

Market Cap254.88B
Enterprise Value358.02B
P/E Ratio8.21
PEG Ratio0.13
Price/Sales Ratio0.54
Price/Book Ratio0.55
Enterprise/Revenue0.86
Enterprise/EBITDA-7.76

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.06
Operating Margin-0.05
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.07

Income Statement

Revenue272.24B
Revenue/Share16,482.09
Gross Profit116.35B
EBITDA13.31B
Net Income6.9B
Diluted EPS375.42

Balance Sheet

Total Cash16.87B
Total Cash/Share1,000.71
Total Debt103.67B
Total Debt/Equity0.41
Current Ratio0.88
Book Value Per Share15,245.76

Price History

52-Week Change-38.57
52-Week High15,260
52-Week Low6,560
Moving Average 50 Days7,481.8
Moving Average 200 Days10,871.7

Statistics

Average Volume452
Shares Outstanding18.17M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate155
Trailing Annual Dividend Yield1.87
Payout Ratio0.22
Last Split Factor2:1
Last Split DateJune 28, 2006
AD